| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 04/25/2007 | CN1312127C 2-cyano-4-fluoropyrrolidine derivative or its salt |
| 04/25/2007 | CN1312086C Process for producing cyclic compound |
| 04/25/2007 | CN1311988C Imide compounds and optical recording media made by using the same |
| 04/24/2007 | US7208515 Diphenylmethyl compounds useful as muscarinic receptor antagonists |
| 04/24/2007 | US7208513 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
| 04/24/2007 | US7208505 Treating Type 2 diabetes and/or obesity; compounds are indoles substituted at position 3 with a (3-(2-(heterocycle-substituted)phenoxy)-2-hydroxypropylamino)alkyl group |
| 04/24/2007 | US7208504 Bicyclic inhibitors of hormone sensitive lipase |
| 04/24/2007 | US7208499 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 04/24/2007 | US7208493 Vasculostatic agents and methods of use thereof |
| 04/24/2007 | US7208488 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling |
| 04/24/2007 | US7208487 Inhibitors of KSP, a mitotic kinesin for treating proliferative diseases such as cancer; 3-Benzyl-7-chloro-2-[2-methyl-1-(7-oxo-[1,4]diazepan-1-yl)-propyl]-3H-quinazolin-4-one for example |
| 04/24/2007 | CA2281545C N-heterocyclic derivatives as nos inhibitors |
| 04/24/2007 | CA2197793C New multimerizing agents |
| 04/24/2007 | CA2194503C 2-[(dihydro)pyrazol-3'-yloxymethylene]anilides, their preparation and their use |
| 04/24/2007 | CA2075173C Compounds and methods for inhibition of hiv and related viruses |
| 04/19/2007 | WO2007044729A2 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors |
| 04/19/2007 | WO2007044515A1 Azetidines as mek inhibitors for the treatment of proliferative diseases |
| 04/19/2007 | WO2007044215A1 Hexahydro cyclooctyl pyrazole cannabinoid modulators |
| 04/19/2007 | WO2007043677A1 Hydrazide compound and pesticidal use of the same |
| 04/19/2007 | WO2007043653A1 Benzimidazole-5-carboxamide derivative |
| 04/19/2007 | WO2007043401A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007043400A1 Nitrogenated aromatic heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007042912A2 Heterocyclic compounds as pstat3/il-6 inhibitors |
| 04/19/2007 | WO2007042815A1 Compounds containing more than one human neutrophil elastase inhibiting moiety for use in the treatment of respiratory diseases |
| 04/19/2007 | WO2007042786A2 4 -heteroaryl pyrimidine derivatives and use thereof as protein kinase inhibitors |
| 04/19/2007 | WO2007042546A1 Imidazole derivatives for the treatment of anxiety and related diseases |
| 04/19/2007 | WO2007042545A1 Imidazole derivatives and their use for modulating the gaba-a receptor complex |
| 04/19/2007 | WO2007042161A1 Process for the preparation of candesartan cilexetil |
| 04/19/2007 | WO2007041923A1 Reagents for highly specific detection of peroxynitrite |
| 04/19/2007 | WO2007020502A3 Cannabinoid receptor ligands and uses thereof |
| 04/19/2007 | WO2007017546A3 Method of obtaining tryptamine derivatives |
| 04/19/2007 | WO2007015923A3 Benzimidazoles useful as inhibitors of protein kinases |
| 04/19/2007 | WO2007009706A3 Substituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood |
| 04/19/2007 | WO2007006534A3 Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity |
| 04/19/2007 | WO2006135669A3 RESOLUTION OF ENANTIOMERIC MIXTURES OF β-LACTAMS |
| 04/19/2007 | WO2006131340A3 Pyrrolones that act as peptide deformylase (pdf) inhibitors |
| 04/19/2007 | WO2006128693A3 2 -oxo-i -pyrrolidine derivatives/ processes for preparing them and their therapeutic use on the central nervous system |
| 04/19/2007 | WO2006116157A3 Dipeptidyl peptidase-iv inhibitors |
| 04/19/2007 | WO2006101217A3 Luminous compound containing lanthanide ion |
| 04/19/2007 | WO2006047492A3 Substituted nitrogen-containing heterocycles as vanilloid receptor ligands and their uses as medicament |
| 04/19/2007 | WO2006034317A3 Chemical compounds |
| 04/19/2007 | US20070088067 Novel amidine compounds for treating microbial infections |
| 04/19/2007 | US20070088062 N-[4-[2-ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl]-2-benzothiazolamine; keratinization disorder such as rosacea, acne, and psoriasis; potent inhibitors of the retinoic acid-metabolism; show little or no endocrinological side-effects; |
| 04/19/2007 | US20070088051 Indolinones and their use as antiproliferative agents |
| 04/19/2007 | US20070088044 Quinazoline derivatives as antitumor agents |
| 04/19/2007 | US20070088042 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 04/19/2007 | US20070088041 Pyridazinone derivatives, methods for their production and their use as pharmaceuticals |
| 04/19/2007 | US20070088033 Diaryl Substituted Pyridinones |
| 04/19/2007 | US20070088032 Processes for the Preparation of Benzoimidazole Derivatives |
| 04/19/2007 | US20070088028 17-Acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 04/19/2007 | US20070088026 5-phenylpyrimidines, their preparation, intermediates for their preparation, and their use for controlling harmful fungi |
| 04/19/2007 | US20070088018 Cb1 antagonist compounds |
| 04/19/2007 | US20070087998 Imidazole compounds that modulate HSP90 activity |
| 04/19/2007 | US20070087452 Luminescent lanthanide complexes |
| 04/19/2007 | US20070085074 Merocyanine dye and use thereof |
| 04/19/2007 | CA2625974A1 Imidazole derivatives for the treatment of anxiety and related diseases |
| 04/19/2007 | CA2625219A1 Heterocyclic compounds as pstat3/il-6 inhibitors |
| 04/19/2007 | CA2624598A1 Reagents for highly specific detection of peroxynitrite |
| 04/19/2007 | CA2623768A1 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors |
| 04/19/2007 | CA2623535A1 Hexahydro cyclooctyl pyrazole cannabinoid modulators |
| 04/19/2007 | CA2623327A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | CA2623202A1 Hydrazide compound and pesticidal use of the same |
| 04/19/2007 | CA2622755A1 Mek inhibitors and methods of their use |
| 04/18/2007 | EP1773824A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 04/18/2007 | EP1773821A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 04/18/2007 | EP1773819A1 Porphyrin linked metronidazole against gum disease: porphyromonas gingivalis |
| 04/18/2007 | EP1773818A2 Preparation of hydrochloride salts of tetrazole derivative |
| 04/18/2007 | EP1773817A1 Substituted aryl-amine derivatives and methods of use |
| 04/18/2007 | EP1773815A2 Mitotic kinesin inhibitors |
| 04/18/2007 | EP1773807A2 Kinase inhibitors |
| 04/18/2007 | EP1773788A2 Quinazoline derivatives |
| 04/18/2007 | EP1773786A2 Five-membered heterocycles useful as serine protease inhibitors |
| 04/18/2007 | EP1773784A2 Anti-inflammatory medicaments |
| 04/18/2007 | EP1773781A2 Indazoles useful in treating cardiovascular diseases |
| 04/18/2007 | EP1773768A2 Pyrrole derivatives as pharmaceutical agents |
| 04/18/2007 | EP1773763A1 Lysine based compounds |
| 04/18/2007 | EP1773756A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 04/18/2007 | EP1773330A2 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 04/18/2007 | EP1553949B1 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 04/18/2007 | EP1458386B1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 04/18/2007 | EP1406893B1 Pyrrolidine bicyclic compounds |
| 04/18/2007 | EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/18/2007 | EP1036066B1 Substituted pyrimidine and pyridine herbicides |
| 04/18/2007 | CN1950393A Novel inhibitors of hepatitis c virus ns3 protease |
| 04/18/2007 | CN1950365A Indolyl derivatives as liver-X-receptor modulators |
| 04/18/2007 | CN1950360A Substituted pyrrole-2, 5-diones as protein kinase c inhibitors |
| 04/18/2007 | CN1950345A Morpholinylanilinoquinazoline derivatives for use as antiviral agents |
| 04/18/2007 | CN1950343A Basic amine compound and use thereof |
| 04/18/2007 | CN1950085A 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors |
| 04/18/2007 | CN1950082A Bicyclic and bridged nitrogen heterocycles |
| 04/18/2007 | CN1949966A Quinoxalin-2-one derivatives, crop protection agents comprising the same and method for production and use therof |
| 04/18/2007 | CN1310907C Heterocyclic compound and antitumour agent containing the same as active ingredient |
| 04/18/2007 | CN1310906C Indole-type derivatives as inhibitors of p38 kinase |
| 04/17/2007 | US7205417 Spiro compounds |
| 04/17/2007 | US7205412 Includes a colorant, a solvent and an antibiotic additive produced by binding antibiotic substance to predetermined additive via chemical reaction; improves storage stability and inhibits propagation and growth of bacteria in ink |
| 04/17/2007 | US7205409 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomoderators |
| 04/17/2007 | US7205407 3-Substituted oxindole β3 agonists |
| 04/17/2007 | US7205330 can also modulate the processing of hepatitis C virus (HCV) polypeptide |
| 04/17/2007 | US7205328 Aids viricide |
| 04/17/2007 | US7205318 Inhibitors of trypsin-like serine protease enzymes; for use as anticoagulant agents for therapy of thromboembolic disorders |